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CASE REPORT 
A 17-year old female presented at the Oral Medicine Clinic 
with the complaint of persistent swelling of the upper lip and 
anterior attached gingiva, causing her discomfort when eating 
and talking. The swelling started approximately ten months 
earlier. At the time she was seen by her physician who pre-
scribed an antibiotic that gave mild symptomatic relief, but no 
clinical resolution. She was also seen by an oral hygienist on 
three occasions with no improvement of the gingival swelling. 
The patient also reported that she had been diagnosed with 
depression and type 2 diabetes approximately two years ago 
and was currently using Citalopram (a selective serotonin re-
uptake inhibitor) and Glucophage® (metformin hydrochloride, 
an anti-hyperglycemic drug). Extra-oral examination revealed 
a firm, swollen and superficially cracked upper lip with a red 
granular appearance. No enlarged cervical lymph nodes 
could be palpated. Intra-orally, the anterior maxillary and man-
dibular gingivae were hyperplastic and erythematous, with a 
granular surface (Figures 1, 2 and 3). The differential diag-
nosis included contact allergy and granulomatous disease, 
including mycobacterial infection. 
An incisional biopsy of the labial surface of the upper lip was 
performed and the patient was provided with an antibacte-
rial mouthwash, (0.2% aqueous solution of chlorhexidine glu-
conate) and instructed to return for further management two 
weeks later. Histological evaluation of the incisional biopsy from 
the upper lip disclosed non-necrotising granulomatous inflam-
mation. The non-necrotising granulomas were composed of 
epitheloid histiocytes and Langhans-type multinucleated giant 
cells, surrounded by a rim of lymphocytes (Figures 4 and 5). 
The Ziehl-Neelsen stain was negative for acid-fast bacilli and 
the Periodic Acid Schiff stain failed to reveal any fungal ele-
ments. Based on the histological features, the clinical findings 
and the special stain results, the clinical diagnosis of orofacial 
granulomatosis (OFG) was established. 
Since OFG could be associated with other systemic condi-
tions or linked to a hypersensitivity reaction ,(some elements in 
the diet or present medication), the patient was referred to the 
Department of Internal Medicine at the local academic hospital 
to establish the underlying aetiology. At the time of publication 
of this report a definitive cause was still awaited.
DISCUSSION
Orofacial granulomatosis (OFG) is an uncommon inflammatory 
disorder, typically presenting as a granulomatous cheilitis, re-
sulting in non-tender swelling and enlargement of one or both 
lips and usually also of the oral tissues.1 The condition may 
cause significant cosmetic and functional discomfort and al-
though unequivocal evidence lacks, the swellings appears to 
be the result of lymphoedema, caused by granulomas disrupt-
ing normal lymph drainage. The age of onset is usually during 
adolescence or young adulthood with an equal gender and ra-
cial distribution.2 The clinical signs may be persistent or present 
as recurrent episodes.3 The initial swelling usually subsides 
within a couple of days, however with subsequent attacks, the 
swelling becomes permanent and increases in severity. The 
swelling is asymptomatic and non-pruritic and has a soft, firm 
or nodular texture on palpation. The normal lip architecture is 
eventually altered by persistent lymphoedema and non-ca-
seating granulomas. Once the swelling has become chronic, 
the enlarged lips tend to become painful due to the formation 
of cracks and fissures and may eventually develop a reddish 
brown discolouration with a scaly, rubbery texture.2,4
Oral lesions are seen in most cases of OFG. The oral lesions 
appear as enlargements of the lingual, palatal, gingival or buccal 
mucosa, with a granular surface texture and may eventually give 
rise to a “cobblestone” appearance, frequently with the presence 
of mucosal tags. In some cases linear ulcers can develop in 
the buccal sulcus. The dorsum of the tongue may present with 
fissuring and rarely, palsy of the facial nerve may arise, due to 
granulomatous involvement of the nerve trunk.1,4 The simultane-
ous presence of tongue fissuring, labial enlargement and palsy 
of the facial nerve are the classical features of the Melkersson-
Rosenthal syndrome.5 OFG may be accompanied by systemic 
symptoms of fever and other mild constitutional symptoms, in-
cluding headache and visual disturbances. The patient may also 
complain of loss of taste sensation and a decreased saliva flow. 
Cervical lymph node enlargement may also be present.
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ANCA:  Anti-Neutrophil Cytoplasmic Antibody  
CT:  Computerised Tomography 
NSAID:  Nonsteroidal Anti-Inflammatory Drug
OFG:  Orofacial Granulomatosis
PCR:  Polymerase Chain Reaction
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Histopathological examination typically shows non-caseating granulomata.5 The 
exact aetiopathogenesis of OFG is unknown and therefore the ideal treatment and 
long-term prognosis is uncertain. It is thought that the condition is due to a de-
layed type of hypersensitivity reaction, but the responsible antigen(s) inducing the 
immunological reaction is/are uncertain and appear to vary from case to case. In 
many patients there is a strong history of atopy and the condition may develop in 
response to metals, such as cobalt, or various food additives and preservatives, 
including cinnamon, benzoates, butylated hydroxyinosole, dodecyl gallate (found 
in margarine), menthol, chocolate and tartrazine. Patients have also reported reac-
tions occurring in response to certain toothpastes and possibly drugs.2,3,5 
OFG is a diagnosis of exclusion, as various conditions produce similar histopatho-
logic and clinical features.2 The early stages of OFG are clinically difficult to dif-
ferentiate from angioedema but the persistence of the swelling between attacks 
should raise suspicion of OFG. Other conditions to be excluded, include Crohn’s 
disease, sarcoidosis, foreign body reactions, mycobacterial infection (such as tu-
berculosis and leprosy) and contact allergy.6 About 10 % of patients with OFG have 
associated Crohn’s disease which should be excluded by ileocolonscopy and ap-
proximately 3% of cases have sarcoidosis, best excluded by radiological studies, 
(eg, chest CT for hilar adenopathy).1,2 Other causes of non-caseating granuloma-
tous inflammation, even though highly unlikely, such as Wegener’s granulomatosis, 
(which hisotologically presents with subacute inflammation, abscess formation and 
vasculitis), should be excluded by appropriate clinical investigations, (eg. meas-
urement of serum c-ANCA and p-ANCA antibodies). Although special stains for 
mycobacterial and fungal infections were negative in this case, such infections can 
only be definitively excluded by culture or PCR.
The treatment of OFG can pose a challenge and spontaneous remission of 
orofacial swelling is rare. Elimination diets should be utilised to identify possible 
precipitating dietary substances and likewise, other possible precipitating anti-
gens. Topical, intra-lesional and systemic corticosteroids can be utilised for con-
servative management of the condition. Triamcinolone acetonide, used at a dose 
of 0,5-1ml of a 10mg/ml solution, is often used for the intra-lesional injections 
and for systemic administration, prednisone is prescribed at a dosage of ap-
proximately 1mg/kg body weight. Chronic corticosteroid administration should, 
however, take cognisance of the associated side effects produced, by adrenal 
cortex suppression and the dosage adjusted accordingly. If there is severe oral 
or extra-oral involvement, clofazimine (an immunosuppresive drug, originally de-
veloped as treatment for leprosy), is used at a dosage of 100-200mg daily for 3-6 
months. Other therapies include NSAIDs, sulfasalazine (a sulfa drug, used for the 
treatment of inflammatory bowel disease and Crohn’s disease), antibiotics (such 
as metronidazole) and anti-malarials (such as hydroxychloroquine). Patients with 
OFG must be regularly reviewed to identify any gastro-intestinal involvement.5,6,7 
CONCLUSION
Although OFG is a rare condition, the dental practitioner should keep this condition 
in mind when a patient presents with unexplained swelling of the lip and hyperplas-
tic oral lesions. In such cases, a careful clinical history should be taken and the 
patient referred to a specialist if no reason can be identified for the lip swelling and/
or gingival enlargement. The diagnosis of OFG requires careful clinico-pathological 
correlation and elimination of all possible causative antigens.
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CASE BOOK
Figure 1: The patient presented with chronic swell-
ing of the upper lip. Note the superficial cracks and 
fissures. 
Figure 2: Marked hyperplasia of the upper anterior 
attached gingiva.
Figure 3: The gingival tissue of the anterior lower arch 
showed slight enlargement with a granular surface.
Figure 4: This photomicrograph shows several non-
necrotising granulomata within the sub-epithelial con-
nective tissue (H&E, x100)
Figure 5: This photomicrograph shows a non-necro-
tising granuloma, consisting of epithelioid histiocytes, 
Langhans-type multi-nucleated giant cells and a rim 
of lymphocytes (H&E, x200)
